Reference Document 2016

The present original French "Document de Référence" of this translated Reference Document was filed with the Autorité des Marchés Financiers on 22 February, 2017, in accordance with Article 212 - 13 of its "règlement général". It may be used in connection with an offering of securities if it is supplemented by a prospectus ("note d'opération") for which the Autorité des Marchés Financiers has issued an endorsement. This Reference Document has been made out by the issuer and engages the responsibility of his signatory.

This Reference Document incorporates by reference the preceding Reference Documents
D.16 - 0078 filed on 25 February 2016 and D.15 - 0090 filed on 27 February 2015.

The following information is included by reference in the present Reference Document:

  • The year 2015 consolidated financial statements of Sartorius Stedim Biotech prepared using international accounting standards and the report of the statutory auditors relating to these statements, and the Group 2015 management report appearing on pages 112 to 156 and 18 to 62 respectively, of the Reference Document filed with the Autorité des Marchés Financiers on 25 February 2016, under the number D.16 - 0078.
  • The year 2014 consolidated financial statements of Sartorius Stedim Biotech prepared using international accounting standards and the report of the statutory auditors relating to these statements, and the Group 2014 management report appearing on pages 103 to 148 and 18 to 56, respectively, of the Reference Document filed with the Autorité des Marchés Financiers on 27 February 2015, under the number D.15 - 0090.

The sections of these documents not included are not of interest to an investor, and are covered in another part of this Reference Document.

Copies of the present Reference Document can be obtained from the following: